Last reviewed · How we verify

GCP-Service International West GmbH — Portfolio Competitive Intelligence Brief

GCP-Service International West GmbH pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

DrugGenericPhaseClassTargetAreaFirst approval
Intravenous 0.9% Sodium Chloride Intravenous 0.9% Sodium Chloride marketed Crystalloid fluid / Electrolyte replacement solution Fluid and electrolyte management

Therapeutic area mix

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

  1. Dr. Waseem Ullah · 1 shared drug class
  2. Fayoum University Hospital · 1 shared drug class
  3. Hospital Central "Dr. Ignacio Morones Prieto" · 1 shared drug class
  4. Hospital Italiano de Buenos Aires · 1 shared drug class
  5. Hvidovre University Hospital · 1 shared drug class
  6. Hédi Chaker Hospital · 1 shared drug class
  7. Kecioren Education and Training Hospital · 1 shared drug class
  8. Krankenhaus Barmherzige Schwestern Linz · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for GCP-Service International West GmbH:

Cite this brief

Drug Landscape (2026). GCP-Service International West GmbH — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/gcp-service-international-west-gmbh. Accessed 2026-05-17.

Related